Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
21 hedge funds and large institutions have $2.3M invested in Nymox Pharmaceutical Corp in 2013 Q2 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
92% less call options, than puts
Call options by funds: $18K | Put options by funds: $225K
Top Buyers
Top Sellers
NYMX Hedge Fund Activity: Q2 2013 in Review
21 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q2 2013, worth a combined $2.3M.
Buyers outnumbered sellers: 21 funds opened new NYMX positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.
- 21 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $2.3M of Nymox Pharmaceutical Corp stock for Q2 2013.
- 21 funds opened new Nymox Pharmaceutical Corp positions in Q2 2013 and 0 closed out, a net change of +21 holders.
Based on aggregated 13F filings for Q2 2013.